Owlstone Medical Overview
- Founded
-
2003
- Status
-
Private
- Employees
-
200
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$60.4M
- Investors
-
8
Owlstone Medical General Information
Description
Developer of breathalyzer designed to focus on non-invasive diagnostics for the early detection of disease and on precision medicine. The company is developing a biopsy product and a proprietary sample collection device that can take stable breath samples anywhere, enabling doctors to avail detection of diseases including lung cancer, liver disease, digestive health, and respiratory disease.
Contact Information
Website
www.owlstonemedical.com
Formerly Known As
Tiger Dawn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 183 Cambridge Science Park
- Milton Road
- Cambridge CB4 0GF
- England, United Kingdom
+44 01223 000000
Owlstone Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series D) | 31-Aug-2021 | $60.4M | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC | 01-Oct-2018 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
| 5. Grant | 25-Jan-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
| 4. Later Stage VC | 27-Mar-2017 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC | 06-Jan-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Grant | 11-Dec-2016 | $1.38M | $7.27M | Completed | Generating Revenue | |
| 1. Angel (individual) | 28-Jun-2016 | $7.27M | $7.27M | 000.00 | Completed | Generating Revenue |
Owlstone Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | 0,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| D Ordinary | 0,000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| A Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| C Ordinary | 00,000 | 00.000000 | 000 | 000 | 00 | 000 | 0.000 | |
| C Ordinary | 0,000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 | |
| C Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00 | |
| C Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| C Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| C Ordinary | 443,787 | $0.000138 | $17.83 | $17.83 | 1x | $17.83 | 3.21% | |
| Convertible C | 376,330 | $0.000138 | $18.09 | $18.09 | 1x | $18.09 | 2.72% |
Owlstone Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of breathalyzer designed to focus on non-invasive diagnostics for the early detection of disease and on precis
Diagnostic Equipment
Cambridge, United Kingdom
200
As of 2022
00000
0000
0000-00-00
00000000000
00000
000000
rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000 000000000
Louisville, KY
0
As of 0000
000
000
0000-00-00
000000000
000
000000
tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000 000000000
Angelholm, Sweden
000
As of 0000
0000
0000-00-00
000000&0
Add Comparison
Owlstone Medical Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Breath Diagnostics | Venture Capital-Backed | Louisville, KY | 0 | 000 | 000000000 | 000 |
| 0000000 | Corporate Backed or Acquired | Angelholm, Sweden | 000 | 000000&0 | ||
| 00000 0000000 | Private Equity-Backed | Orlando, FL | 0000 | 000.00 | 000000000000 | 000.00 |
| 00 0000000000 | Corporation | Boston, MA | 00000 | 000 | ||
| 0000000 | Venture Capital-Backed | Fitchburg, WI | 0 | 00.000 | 00000000000 | 00.000 |
Owlstone Medical Patents
Owlstone Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202208155-D0 | Method | Pending | 01-Jun-2022 | ||
| GB-202207291-D0 | Detection of liver disease | Pending | 18-May-2022 | ||
| GB-202114706-D0 | Method | Pending | 14-Oct-2021 | ||
| GB-202110582-D0 | Breath sampling device | Pending | 22-Jul-2021 | ||
| GB-202107203-D0 | Formulation | Inactive | 20-May-2021 |
Owlstone Medical Executive Team (11)
Owlstone Medical Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andy Richards Ph.D | Self | Chairman | 000 0000 |
| Billy Boyle | Owlstone Medical | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Bret Bader | Self | Board Member | 000 0000 |
| Christofer Toumazou Ph.D | Self | Board Member | 000 0000 |
| Doug Wright | Aviva Ventures | Board Member | 000 0000 |
Owlstone Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Owlstone Medical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Hon Hai Precision | Corporation | Minority | 000 0000 | 000000 0 | |
| Horizons Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| V Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| IPF Catalyst Challenge | Not-For-Profit Venture Capital | 000 0000 | 000000 0 | ||
| Aviva Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |